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ABSTRACT: Gold nanocages (AuNCs) have been shown to be a useful tool for harnessing 
imaging and hyperthermia therapy of cancer, thanks to their unique optical properties, low 
toxicity and facile surface functionalization. Herein, we use AuNCs for selective targeting of 
prostate cancer cells (PC3) via specific interaction between neuropeptide Y (NPY) receptor and 
three different NPY analogs conjugated to AuNCs. Localized surface plasmon band of the 
nanoconjugates was set around 800 nm, which is appropriate for in vivo applications. Long-term 
stability of nanoconjugates in different media was confirmed by UV-vis and DLS studies. Active 
NPY receptor targeting was observed by confocal microscopy showing time-dependent AuNCs 
cellular uptake. Activation of ERK1/2 pathway was evaluated by Western blot to confirm the 
receptor-mediated specific interaction with PC3. Cellular uptake kinetics were compared as a 
function of peptide structure. Cytotoxicity of nanoconjugates was evaluated by MTS and 
Annexin V assays, confirming their safety within the concentration range explored. 
Hyperthermia studies were carried out irradiating the cells, previously incubated with AuNCs, 
with a pulsed laser at 800 nm wavelength, showing a heating enhancement ranging from 6 to 35 
°C above the culture temperature dependent on the irradiation power (between 1.6 and 12.7 
W/cm2). Only cells treated with AuNCs underwent morphological alterations in the cytoskeleton 
structure upon laser irradiation, leading to membrane blebbing and loss of microvilli associated 
to cell migration. This effect is promising in view of possible inhibition of proliferation and 
invasion of cancer cells. In summary, our Au-peptide NCs proved to be an efficient theranostic 
nanosystem for targeted detection and activatable killing of prostate cancer cells. 
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INTRODUCTION 
A great challenge in modern oncology resides in the detection, localization and treatment of 
tumor neoplasms, especially at early stages of development. Among different conventional 
strategies used to selectively target cancer cells, monoclonal antibodies have become a magic 
bullet.
1,2
 However, numerous drawbacks in antibody treatments have appeared with time, 
including poor pharmacokinetics and biodistribution as well as compromised functionality of the 
immune system,
3
 making this solution more complicated than expected.
4
 As an alternative to the 
use of antibodies, synthetic peptides reminiscent of those naturally occurring in the human 
organism, so called regulatory peptides, are gaining increasing interest in cancer research.
5
 Short 
peptides can be easily synthesized using automated synthesizers and their pharmacokinetic 
profiles can be improved by making appropriate changes in the peptide sequence. Regulatory 
peptides include brain neuropeptides, gut peptide hormones, vasoactive peptides, and peptides of 
the endocrine system, and act on multiple targets in the human body modulating the function of 
most key organs and metabolic processes.
6
 More recently, these regulatory peptides have been 
suggested as powerful small ligands for cancer targeting, as several peptide receptors were found 
overexpressed in certain tumors, and indicated for use as markers for localization of tumors and 
of their metastases.
7
 Actually, advanced clinical diagnosis of cancer takes advantage of 
molecular receptor targeting by radiolabeled peptides.
3,8
 The major challenge for radiolabeling is 
to find a compromise between peptide and radionuclide dosages: a minimum amount of peptide 
is needed to reduce any adverse pharmacologic effects, while high specific radioactivity is 
crucial for optimal resolution. On the other hand, the potential of nuclear imaging techniques 
(PET, SPECT) is limited by the cost of radionuclides with short half-lives and relatively poor 
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resolution. In the last decade, great efforts have been made to develop new kinds of imaging 
agents taking advantage of the progress made by nanoparticle research.
9
 Among myriads of 
nanoparticles, gold nanocages (AuNCs), versatile nanostructures characterized by hollow 
interiors and ultrathin porous walls, have attracted a great attention thanks to their unique optical 
properties associated to a tunable localized surface plasmon resonance (LSPR).
10
 The two- and 
three-photon luminescence capabilities and strong optical absorption of AuNCs allow labeling 
and quantitatively tracking the cells using two-photon and photoacoustic microscopy, therefore 
providing valid alternative to radiolabeling.
11,12,13
 In addition, AuNCs have been used as 
promising agents for noninvasive photothermal therapy taking advantage of the large absorption 
cross-section in the near infrared (NIR) region of the optical spectrum.
14,15
 More recently gold 
nanoparticles have been shown to display substantial Joule heating under radiofrequency fields, 
opening up their application in MRI therapy,
16,17
 though the mechanisms and efficiency of this 
effect is still under debate. Finally, the easy functionalization of AuNCs with thiol-containing 
molecules through Au-S covalent interaction make them excellent nanoconjugates for use as 
tumor targeting agents. Combined together, these features give rise to an efficient 
multifunctional nanotheranostics able to label and detect tumor cells via specific targeting of 
molecular receptors and to induce their irreversible death through NIR-assisted 
hyperthermia.
18,19,20
  
Despite the remarkable progress in the field of small peptides as targeting agents, the 
exploration of new peptide receptors overexpressed preferentially by human cancers remains an 
attractive goal in order to optimize the therapeutic possibilities toward a personalized cure. In 
this context, neuropeptides play a crucial role being not only potent cellular growth factors in 
normal cells, but also responsible for autocrine/paracrine stimulation of tumor cell proliferation 
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and migration.
5
 Neuropeptide Y (NPY) is a 36 amino acid peptide that acts as a neurotransmitter 
and neuromodulator and, in humans, exerts its effect through a family of four G-protein coupled 
receptors, namely, Y1, Y2, Y4, and Y5. In particular, the expression of Y1, Y2, and Y5 receptors 
is associated with different stages of either carcinogenesis or tumor progression.
5
 Recent studies 
by Magni et al. explored the expression of Y1-R gene in prostate cancer cells and the role of 
NPY in regulating tumor growth.
21
 However, the attention has been mostly focused on GPCR 
itself so far, while the data regarding NPY receptor (NPYR) targeting in prostate cancer are still 
lacking. Aiming to explore the potential of NPYR targeting in the treatment of prostate cancer, 
we prepared gold nanocages functionalized with three short peptides – derivatives of NPY – 
specific to NPYR (Y1/Y2). These Au-peptide nanocages were first assessed in terms of targeting 
efficiency in PC3 prostate cancer cells. Next, the nanoconjugates were exploited as probes for 
confocal microscopy and as heating mediators for light-triggered cancer thermotherapy, taking 
advantage of the theranostic character of AuNCs (Figure 1). 
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Figure 1. Schematic representation of NPYR targeting on prostate cancer cells by peptide-
functionalized gold nanocages and subsequent hyperthermia by NIR irradiation. Three kinds of 
AuNCs are considered, deriving from the surface functionalization with selected peptides, 
namely a) Au-CALNN-INP, b) Au-CALNN-Ahx-INP, c) Au-CALNN-YIN, respectively. 
Peptide sequences are sketched in the figure. The available surface of AuNCs was saturated by 
short PEG molecules, HS-(CH2)11-EG6-OH. 
 
RESULTS AND DISCUSSION 
Design and synthesis of peptides. The rationale of peptide design was based on the following 
issues: 1) preservation of the native alpha-helical conformation of NPY, essential for the NPYR 
recognition, and 2) successful conjugation of the peptides to AuNCs giving stable nanoparticles 
without compromising the receptor recognition ability. Peptide structures, reported in Figure 1, 
contain a nanoparticle-binding motif (CALNN) and a NPY-binding motif. NPY-binding motifs 
were synthesized according to the results of the studies reported previously.
22
 CALNN 
pentapeptide, successfully used by Levy et al. to favor an ordered peptide assembly on the 
nanoparticle surface, was introduced as a linker for AuNCs stabilization via Au-thiol bond of 
terminal Cys.
23
 As for NPYR binding part, the binding motifs were derived from the C-terminus 
NPY 25-36 fragment - common recognition site for the receptor binding conserved in all of the 
ligands.
24
 In brief, the amidated C-terminus as well as the Arg33 and Arg35 residues were 
conserved for their importance in maintaining the NPYR binding. As for CALNN-INP, Leu30 
was exchanged with Pro in order to increase the fragment activity since the turn-inducing 
sequence Asn29-Pro30 stabilizes the essential helix conformation. To improve the segment 
helicity, Gln34 was also substituted with Leu in all three peptides, while Thr32 was exchanged 
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with aromatic amino acids like Phe or Tyr to increase the peptide-receptor interaction.
25
 In 
CALNN-Ahx-INP, 6-aminohexanoic acid (Ahx) was introduced between the nanoparticle-
binding motif and the NPY-binding motif for two reasons: 1) to study how the sequence CALNN 
could influence the stability of the peptide secondary structure when it is directly or not linked to 
the receptor-binding motif; 2) to study possible effects of an elongation and separation of the 
receptor-binding motif from nanoparticle surface on the targeting efficiency of the 
nanoconjugate. Peptides were synthesized manually by Fmoc-strategy using the Rink Amide 
resin, purified by a preparative HPLC and characterized by analytical HPLC. The identity and 
purity were confirmed by UPLC mass spectrometry. The peptide secondary structure was studied 
by circular dichroism (CD). The CD spectra, shown in the Figure S1, were performed in 
phosphate buffer saline (PBS)/TFE 70:30 (10 µM solutions) in the far-UV region (190-250 nm). 
As expected, in the case of CALNN-INP and CALNN-YIN, the double minima at 208 and 222 
nm and the positive band below 200 nm indicate the presence of a well-defined helical structure. 
The percentage of α-helix in the peptides was calculated with DICHROWEB
26
 using K2d 
method,
27
 which estimated a value of 56% and 55% respectively. Then, the presence of Pro in 
position 30 allowed to maintain the helical secondary structure also with a shorter sequence. In 
CALNN-Ahx-INP, the typical bands of α-helix structure disappeared (only 28% calculated with 
DICHROWEB), but it exhibited a negative band at 218 nm and a positive band at 193 nm, 
typical of an antiparallel β-pleated sheets. These results suggested that the pentapeptide CALNN 
could be considered useful not only for the assembly on the nanoparticle surface, but also for the 
stabilization of the helical structure when it is directly linked to the peptide receptor-binding 
motif. 
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Nanoparticle synthesis and functionalization. PVP-coated AuNCs of 40.8 ± 1.8 nm were 
prepared by well-described galvanic replacement using silver nanocubes as substrates (Figure 2, 
a-c).
28,29
 To prepare the three different batches of functionalized AuNCs, as-synthesized 
nanoparticles were reacted with a mixture of each peptide type and thiolated PEG to allow for 
capping-ligand exchange and Au-S bond formation. As above mentioned, the CALNN sequence 
was used as a spacer between AuNC surface and the targeting moiety. CALNN peptide allowed 
keeping the colloidal stability of nanoconjugates by stabilization of the targeting peptide 
structure and its interaction with the charged nanoparticle surface.
23
 As discovered by Levy et 
al., thanks to the presence of alanine and leucine in positions 2 and 3 promoting the self-
assembly of the peptide through intermolecular hydrophobic interactions, CALNN peptide is 
able to form a self-assembled monolayer on gold nanoparticles, donating to nanoparticles 
extremely stable properties.
30
 
AuNC functionalization resulted in a large shift of UV-Vis plasmon absorption from 802 to 
860 nm, characteristic of the dielectric constant change due to peptide and PEG conjugation to 
the particle surface (Figure 2d). This was also confirmed by changes in electrokinetic and size-
distribution features of nanoparticles determined by DLS and zeta-potential analyses. The 
hydrodynamic size of the nanoconjugates slightly increased, while their zeta-potential values 
became less negative compared to non-functionalized nanocages (see Table 1). The peptide 
amount per particle was evaluated by UV-vis spectroscopy on washing supernatant by 
subtracting a reference blank obtained as a mixture of PEG and dimethylsulfoxide at the same 
amounts and conditions of the reaction. On average, we found around 2000 peptide molecules 
per particle (Table 1). The long-term colloidal stability was monitored by DLS and zeta-potential 
measurements for several months after peptide conjugation, (Figure S2). The nanoparticles were 
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highly stable in mQ water as monitored by UV-vis spectroscopy and after incubation in different 
buffer solutions, including acetate buffer (pH 4.5), 20 mM HEPES (pH 7.8), 2.5 mM NaCl (pH 2 
and pH10) and fetal bovine serum (FBS) (Figure S3, a-c). Surprisingly, all nanoconjugates were 
found to be stable both in 100% FBS and in acidic sodium chloride solution (pH 2), as confirmed 
by the very slight changes in the position and intensity of the plasmonic band.  Halas et al. have 
investigated the stability of Ag-Au hollow nanospheres across a range of different pH and in 
human serum at physiological pH.
24
 Disappointingly, the authors noticed that the structural 
integrity of the hollow architecture was compromised both in serum and in strongly acidic pH 
causing the in vivo degradation of AuNCs. 
 
 
Figure 2. a) TEM micrographs of as-prepared silver nanocubes - medium size 34.7 ± 2.5 nm 
(scale bar 50 nm); b) TEM micrographs of as-prepared Au-PVP NCs (scale bar 500 nm); c) TEM 
micrographs of as-prepared Au-PVP NCs – medium size 40.8 ± 1.8 nm (scale bar 50 nm); d) 
UV-vis spectra of AuNCs before and after functionalization with peptides. 
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This effect was attributed to the presence of Ag on the inner surface of the nanoparticles 
leading to oxidation and consequent alteration of the integrity of the particles. In contrast, the 
structural integrity of our AuNCs was maintained in FBS, and no silver leakage was observed by 
TEM analysis. This improved stability is attributable to the presence of Au layers both inside and 
outside the cage walls, protecting them from oxidation and making them stable under the 
aggressive biological conditions (Figure S3).
25
 Moreover, a careful design of the ligand shell to 
protect the nanoparticles from aggregation, using both CALNN pentapeptide and PEG at right 
proportion, has contributed to the particle stability even at harsh conditions.
30 
 
Table 1. Hydrodynamic size (DLS), zeta-potential and ligand shell composition of nanoparticles: 
1 - Au-PVP, 2 - Au-CALNN-INP, 3 - Au-CALNN-YIN, 4 - Au-CALNN-Ahx-INP. 
N° Hydrodynamic size, nm Zeta-potential, mV peptide/NP 
1 44.25 ± 13.45, PDI 0.154 –32.7 ± 4,20 – 
2 45.56 ± 12.87, PDI 0.189 –5.66 ± 7.47 2.04 × 10
3
 
3 51.92 ± 14.27, PDI 0.160 –4.80 ± 5.62 1.67 × 10
3
 
4 50.04 ± 17.51, PDI 0.225 –4.11 ± 3.98 2.50 × 10
3
 
 
NPYR targeting. A nanoconjugate drug or diagnostic agent with potential impact in the 
clinics should have a distinct capacity to target the disease in-situ. Either passive or active 
targeting have been explored in details so far. Besides the “enhanced permeability and retention” 
(EPR) effect, passive targeting largely exploits also intrinsic physico-chemical characteristics of 
nanoparticles, including charge, size, shape and material composition.
31
 For example, cationic 
nanoparticles electrostatically bind to negatively charged phospholipid head-groups exposed on 
the cell surface, while lipid nanoparticles can fuse with the cell membrane and enter the cell 
without involving the interaction with any specific receptor.
32,33
 On the other hand, active 
targeting requires the interaction between a conjugated targeting ligand and a molecular receptor, 
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preferentially a protein or a carbohydrate molecule or cluster, overexpressed on the outer surface 
of the cell.
34
 Competitive binding or using scrambled peptides (or nonspecific antibodies) are 
two major approaches to characterize the active targeting efficiency of functionalized 
nanoparticles. In the first approach, targeted particles are incubated with receptor-positive cells 
in the presence of large (usually 10 to 100-fold) excess of free ligand, so that nanoparticle 
binding is initially hampered by the receptor saturation.
35
 In the second approach, peptides with 
randomly mixed amino acid sequences are used to show decreased binding efficiency of 
nanoparticles.
36
 Both approaches have their advantages and disadvantages and thus multiple 
strategies should be used to assess specific receptor binding. Another approach, commonly used 
in molecular biology to study receptor-ligand interactions, includes the assessment of signal 
transduction activation upon receptor binding. Here we propose to use this approach to prove the 
specific molecular binding of nanoparticles to the cellular receptors, taking advantage of the 
intracellular biochemical events triggered by the receptor binding process. Once cells recognize 
targeting molecules on the nanoparticle surface, they respond to extracellular stimuli by 
engaging specific intracellular programs, including the signaling cascade that leads to the 
activation of regulatory sentinel genes, such as the mitogen-activated protein kinases (MAPKs). 
This chain of reactions, called intracellular signal transduction, allows signal to be transmitted 
from the cell surface to a variety of intracellular targets. We reasoned that the detection of the 
activation/deactivation of different downstream signals induced by the nanoparticle binding to 
the receptor could be a corroborating proof of the involvement of ligand-receptor active 
recognition compared to conventional assays. In other words, when peptide-conjugated 
nanoparticle binds to NPY receptor on PC3 cell, a signaling cascade activation takes place. In 
particular, we focused on the phosphorylation of the extracellular signal-regulated kinase (ERK), 
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which is a pivotal step of the cytosolic signaling pathway associated with NPYR activation. ERK 
belongs to the MAPK pathway, and its activation plays a key role in the signaling process 
leading to cell proliferation induced by growth factors that act through either protein-tyrosine 
kinase or G protein-coupled receptors.
37,38
 Activation of ERK is mediated by the Raf/Ras/MEK 
pathway, where MEK activates members of the ERK family by phosphorylation of both 
threonine and tyrosine residues. Once activated, ERK phosphorylates a variety of targets, 
including other protein kinases and transcription factors.
39
 Lee et al. reported that heregulin-
functionalized nanorods binding to HER2 receptor could stimulate ERK phosphorylation in 
MCF7 breast cancer cells.
40
 The increase in ERK phosphorylation was associated to the 
existence of “active zones,” i.e., dynamic regions in the cell periphery, exhibiting higher rates of 
nanoparticle binding compared to the rest of the cell, suggesting, therefore, a localized receptor 
activation.  
In our experiments, we first confirmed that the chemical modification of peptides required for 
AuNC conjugation did not compromise their ability to bind to the receptors. For this purpose, we 
analyzed ERK phosphorylation after incubation of PC3 cells with free peptides. All experimental 
conditions (peptide concentration, incubation time) were set up basing on our previous 
expertise.
21
 All three peptides at 10
–7
 M concentration induced a significant level of ERK 
phosphorylation within 10 min (Figure 3). As we expected, the comparison between the shortest 
peptide under investigation, i.e., CALNN-INP, and its Ahx-modified analogue showed that the 
highest phosphorylation ratio (∼%) was achieved with the short peptide associated with a good α-
helix conformation. As for CALNN-YIN peptide, its pERK/ERK ratio of reached ∼260-270% at 
10
–7
 M peptide concentration. After 20 min incubation, pERK/ERK ratio decreases in all three 
cases, almost reaching control levels, which is indicative of short-term phosphorylation. 
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Next, in order to assess the downstream intracellular signaling upon nanoparticle binding, ERK 
phosphorylation was measured in PC3 cells targeted with peptide-conjugated AuNCs. Figure 3 
shows that all Au-peptide NCs were indeed able to stimulate ERK activation, therefore 
confirming the occurrence of a specific interaction with NPYR. Generally, the response of ERK 
activation is both enhanced (∼150%-250%) and prolonged (from 10 to 20 min) compared to the 
respective free peptides, depending on the peptide sequence. This effect was likely associated to 
the presence of the nanocage. 
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Figure 3. Time dependence of ERK phosphorylation in PC3 cells in response to specific NPYR 
targeting by nanocages decorated with a) CALNN-INP, b) CALNN-Ahx-INP, and c) CALNN-
YIN peptides. Number of replicates, n = 3. 
Indeed, multivalent interaction between peptides and receptors could take place due to higher 
ligand density on the particle surface leading to higher binding avidity. In addition, the 
distribution of peptide molecules on the nanoparticle surface was regular due to both CALNN 
and PEG contribution, leading to a more appropriate presentation of the peptide binding motif to 
the receptor interaction site. 
Our findings are corroborated by previous evidence by Chan and co-workers that spherical 
gold nanoparticles conjugated with anti-HER2 antibody could firmly anchor on SK-BR-3 cell 
surface, resulting in prolonged receptor binding compared to the antibody alone.
40
 The authors 
showed that nanoparticle size between 40-50 nm is critical to be internalized via receptor-
mediated endocytosis, keeping a balance between multivalent cross-linking of membrane 
receptors and the process of membrane wrapping involved in clathrin polymerization required 
for the endosomal vesicle formation. We evaluated the influence of the peptide structure on the 
interaction with NPYR and, consequently, on ERK stimulation. All peptides showed high levels 
of phosphorylation compared to the control. Unexpectedly, the longer peptide CALNN-Ahx-
INP, once bound to nanoparticle, showed even higher phosphorylation levels compared to its 
shorter analog, CALNN-INP, in contrast to the response of the peptide alone (Figure 3, a, b). Au-
CALNN-YIN NPs confirmed their efficiency showing extremely high pERK/ERK ratios at short 
incubation time, and a prolonged effect up to 60 min after incubation (Figure 3c). 
Assessment of AuNC uptake by confocal microscopy. Thanks to their unique optical 
absorption and scattering properties, gold nanoparticles, as small as 4 nm in size, can be detected 
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inside the cells by laser confocal scanning microscopy in scattering (reflective) mode, as reported 
by Rotello et al.
41
 Also, larger anisotropic gold nanoparticles can be detected in living cells and 
followed in their intracellular dynamics.
42
 In our study, we applied this technique to investigate 
the internalization kinetics of NPY-conjugated AuNCs into PC3 cells. As shown in Figure 4, the 
most part of peptide-conjugated nanoparticles were found either crossing the cellular membrane 
or inside the cells after 1 h of incubation. Quite surprisingly, Au-PVP nanocages missing the 
peptide ligand were hardly taken up by the cells (Figure S5), suggesting very high selectivity of 
peptide-mediated nanoconjugate internalization. As observed from histograms in Figure 4d and 
from the kinetic analysis (Figure S6), Au-CALNN-YIN NPs have the fastest internalization 
kinetics with growth time 3 ± 1 h, and shows an overshooting effect at about 5 h of incubation 
time with a subsequent relaxation time of about 24 ± 1 h. The kinetics of internalization of Au-
CALNN-INP NPs shows a single growth component (Figure S6) with relaxation time = 3 ± 1 h. 
The growth kinetics of its longer analog is slower with growth time = 6 ± 1.3 h. Notably, after 24 
h of incubation, the amount of Au nanocomposites internalized by the cells reached a basically 
common value among the three different Au-peptide nanocages. For a better understanding, full-
size confocal microscopy images are reported in SI (Figure S4A-D). 
These results are in line with the data from ERK-phosphorylation investigations, where the 
highest pERK/ERK ratio was attributed to Au-CALNN-YIN NPs, in fact, showing the fastest 
accumulation kinetics. The major cellular uptake, and, as a consequence, higher pERK level, 
could be attributed to higher affinity of YIN peptide sequence not only to Y1 receptor (ED50 = 9 
nM), but also to Y2 receptor (IC50 = 8 nM), while INP peptide sequence was found to have 
affinity only to Y1 receptor subtype (IC50 = 10 nM versus IC50 = 480 nM for Y2 receptor).
43
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Figure 4. Confocal microscopy images (162 µm × 162 µm) of PC3 cells incubated with peptide-
functionalized AuNCs: a) Au-CALNN-INP NPs; b) Au-CALNN-Ahx-INP NPs; c) Au-CALNN-
YIN NPs. Cellular membranes are stained with AlexaFluor488–conjugated Wheat germ 
agglutinin (green), while AuNCs are visualized in reflection mode (red); d) Cellular uptake 
quantification by confocal microscopy. Scattering signal per cell area is reported after measuring 
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at least 50 cells per sample. The nanoparticle uptake, evaluated by summing the scattering signal 
from all the nanoparticles inside each cell normalized to the cell section area, was averaged over 
at least 50 cells. 
Determination of nanoparticle uptake and trafficking by transmission electron 
microscopy. In order to get insight into the interaction between the nanoconjugates and the 
cellular environment, the nanocage trafficking pathway inside the cells was studied by TEM. 
PC3 cells were incubated with the particles for different periods of time (from 30 min to 48 h) at 
37 °C, then washed, harvested and processed following a common preparation protocol. Figure 5 
and Figure S7 show TEM images of cross-sectioned PC3 cells incubated with Au-CALNN-YIN 
NCs and Au-CALNN-INP NCs, respectively. After 30 min of incubation, AuNCs were found 
confined at the cellular membrane, suggesting the occurrence of ligand binding to the relevant 
NPY receptor. According to the TEM analyses, we speculated that mainly two internalization 
mechanisms were likely to take place, basically micropinocytosis and clathrin-mediated 
endocytosis. In most cases, a well-preserved double membrane of the vesicles characteristic of 
endocytosis pathway could be distinguished. 
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Figure 5. Gallery of TEM images showing cellular trafficking of Au-CALNN-YIN NCs in PC3 
cells. The nanocages were incubated with cells for 30 min, 3, 5, 24 and 48 h, processed and 
visualized by TEM microscopy. Scale bars: a,c) 200 nm; b,e,f) 1 µm; d,g) 500 nm; h) 2 µm 
Small arrows indicate just internalized nanocages, while big arrows indicate clathrin formation. 
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Micropinocytosis took place here when aggregates of particles (i.e., > 300 nm) were 
interacting with the cell membrane, while clathrin-mediated endocytosis was favored in the case 
of a single particle-membrane interaction. A large extent of internalization of AuNCs by PC3 
cells was evident already after short incubation time (3 h), while at longer incubation times (24 h 
and 48 h), the particles were found in the cytoplasm in huge amounts essentially confined into 
endosomes and/or lysosomes. In contrast to what has been reported with peptide-modified gold 
nanospheres, the presence of AuNCs free in cytoplasm was not detected under our experimental 
conditions. This could be interesting in view of a possible thermal effect. The presence of huge 
hot spots, compared to a generalized lower temperature increase that could be obtained by the 
internalization of individual nanocages free in the cytoplasm, could have also an effect on the 
fate of the cells after irradiation. Notably, Au-CALNN-INP NCs preferentially accumulated in 
endosomes, while Au-CALNN-YIN NCs were especially found inside lysosomes.  
Although the cytosolic distribution of AuNCs was not expected to affect the outcome of laser 
treatments significantly, the accumulation of AuNCs in endosomes rather than in lysosomes 
could be instead of importance for the consequences it might have on the fate of the cell. In fact, 
the effect of laser treatment at different stages of nanoparticle confinement is currently under 
investigation in our laboratory. It is also curious to note the presence of nanoparticles close to the 
cellular membrane even after 48 h of incubation. This can be indicative of either exocytosis 
phenomena or prolonged cell uptake. As several images taken from different fields confirmed 
this observation, we reasoned that AuNCs could be partially exocytosed by the cells and 
subsequently re-endocytosed. A similar effect has been described in details by Kanaras et al. 
with spherical gold nanoparticles.
44
 To confirm the hypothesis of the exocytosis/endocytosis 
mechanism, the cells were incubated with Au-CALNN-INP NCs and Au-CALNN-YIN NCs for 
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24 h, carefully washed with buffer to remove all residual nanocages from the matrix and re-
incubated in the fresh media for additional 5 and 24 h. Figure 6 and Figure S8 show the presence 
of nanoparticles inside the vesicles throughout the cell, both close to the nucleus and to the cell 
membrane. As observed, vesicles were trafficked back to the cellular membrane and 
subsequently excreted. Eventually, exocytosed vesicles released the nanoparticles outside the 
cells, which were next endocytosed again (5 h and 24 h). The competitive action of faster and 
predominant endocytosis with slower relaxing exocytosis might be at the origin of the higher 
intracellular concentration of Au-CALLN-YIN constructs observed at 5 h (see Fig. 4 and Fig. 
S12) compared to the equilibrium value reached at longer incubation times (24 h). 
 
Figure 6. Gallery of TEM images showing PC3 cells incubated with Au-CALNN-YIN NCs: the 
cells were treated with nanocages for 24 h and washed with fresh medium (T = 0 h), then re-
incubated for further 5 h (T = 5 h) or 24 h (T = 24 h). Scale bars: a) 2 µm; b,c,e,f) 500 nm; d,g) 5 
µm; h,i) 1 µm. 
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Photothermal ablation of prostate cancer cells. Among different plasmonic nanoparticles, 
the interest in using gold nanocages as a tool for photothermal ablation of cancer has been 
dramatically rising thanks to their unique ability to absorb near-infrared (NIR) light in the 
650−900 nm range, the so-called biologically transparent window.
45,46
 Thus, we moved to 
investigate the efficiency of targeted AuNCs in inducing prostate cancer cell death via 
photothermal treatment. First, we studied the thermal-responsiveness of AuNCs in solution in 
order to define the maximum temperature rise at a given nanoparticle concentration (i.e., 0.4 
nM). We exposed AuNCs in PBS to NIR laser irradiation at 800 nm with laser irradiance varying 
from 1.6 to 12.7 W/cm
2
 for 20 min. Changes in temperature were measured and imaged by a 
thermographic camera over the whole duration of the experiments. As shown in Figure S9, the 
temperature of AuNCs increased from ca. 6 °C at the lowest irradiance (1.6 W/cm
2
) to 35 °C at 
the highest (12.7 W/cm
2
). In contrast, under the same conditions, the temperature of 
nanoparticle-free PBS solution increased only by 2 °C. 
Next, to quantify the photothermal efficiency of nanoconjugates in cell cultures, we assessed 
the cell viability upon treatment with AuNCs. MTS assay was performed on PC3 cells incubated 
with nanoconjugates before and after laser irradiation. Cell viability was not compromised after 
incubation with peptide-conjugated AuNCs at 0.4 nM concentration for as long as 72 h of 
incubation (Figure S10). In contrast, upon irradiating the sample at an irradiance as low as 1.6 
W/cm
2
, cell viability drastically dropped even after the shortest irradiation time (30 sec) (Figure 
S11). At longer irradiation times, cell viability reached a plateau with similar values for all of the 
three nanoconjugates. Due to the experimental conditions, cell viability never reached zero 
values (a minimum 25% was found). This residual viability is likely attributable to the average 
fraction of cell pellet not irradiated In the Eppendorf tube due to the finite size of the laser spot 
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that should be confined in a small volume (1.6-1.8 mm linear size) in order to reach the desired 
irradiance value. Not surprisingly, cell viability was mostly compromised in the case of Au-
CALNN-YIN NPs even after 30 s of irradiation. This result is in line with the cellular uptake 
studies showing the maximum accumulation of Au-CALNN-YIN NCs already after 3 h 
incubation, different from the other two nanoconjugates. 
 
Figure 7. Fluorescence microscopy images of PC3 cells incubated with peptide-conjugated 
AuNCs: a) AuNCs upon NIR irradiation (800 nm, 12.7 W/cm
2
) for 10 min; b) AuNCs upon NIR 
irradiation (800 nm, 12.7 W/cm
2
) for 20 min. Viable cells are stained in green with calcein AM, 
dead cells are stained in red with PI. All images were collected in tile mode: the overall field of 
view is 3.1 ⋅ 3.1 mm. 
In order to assess the tumorigenic cell ablation efficacy of peptide-conjugated AuNCs, we 
visualized the effect of NIR laser irradiation on a large field of view by means of confocal 
microscopy. All irradiation experiments were performed at room temperature. PC3 cells were 
cultured in a glass-bottomed Petri dish and incubated for 3 h with nanoconjugates at a final 
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concentration of 0.4 nM. Cells were irradiated for 10 and 20 min at 10 W/cm
2 
irradiance, then 
stained with calcein AM and propidium iodide (PI) following a standard staining protocol and 
immediately observed by fluorescence microscopy. This assay is based on the conversion of the 
cell permeant non-fluorescent calcein AM dye to the fluorescent analog by intracellular esterase 
activity in live cells,
47
 which allowed us to visualize the alteration of live/dead cells ratio caused 
by the photothermal effect of AuNCs. On the other hand, PI is membrane impermeable and does 
not enter viable cells with intact membranes, while once the cell undergoes membrane damage, 
PI intercalates into nucleic acids giving rise to dramatic fluorescence increase. As shown in 
Figure 7a, following 10 min of irradiation, the cells maintained their viability, even when treated 
with peptide-conjugated nanocages. When irradiation time was increased to 20 min, the cells 
underwent death principally by necrosis: a clear demarcation line between dead (red) and live 
(green) cell regions could be observed in the presence of AuNCs. By contrast, the irradiation of 
the untreated cells with the same laser power did not lead to cell death, confirming the safety of 
our experimental conditions. Moreover, the irradiation of plated cells at irradiance at 2 W/cm
2
 or 
below did not produce any significant reduction of the calcein staining. This disagreement with 
the data from confocal microscopy raised a question: were the calcein-positive cells really alive 
or did they rather underwent cell death pathway, which could not be detected by this kind of 
staining? In order to resolve this question, more detailed studies on apoptosis pathway will be 
necessary. Temperature increase was recorded by a thermocamera while irradiating cells 
incubated either with Au-PVP NCs or with Au-peptide NCs. Thermograms shown in Figure 8 
suggested that, at 12.7 W/cm
2
 irradiance and 5 min irradiation time, control cells that were not 
incubated with AuNCs exhibited a negligible temperature change around 1 °C.  
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Figure 8. Upper panel: Time-dependent temperature-rise images of PC3 cells incubated with 
peptide-conjugated AuNCs, Au-PVP NCs and control cells. The pictures were obtained by 
thermocamera during laser exposure and show the Petri dish (35 mm diameter) with the central 
irradiated area. Lower panel: Time-dependent temperature-rise curves of PC3 cells incubated 
with peptide-conjugated AuNCs, Au-PVP NCs and control cells. Time interval: 5 min. Laser 
irradiance 12.7 W/cm
2
, 800 nm. 
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When incubated with Au-PVP NCs, the temperature rise was slightly higher, but did not even 
reach 25 °C. This is in agreement with the low cellular uptake of these particles in PC3 cells. In 
contrast, when cells were incubated with Au-CALNN-INP NPs, the thermocamera revealed a 
significant heating with temperature approaching 35 °C, while even higher values, i.e., close to 
44-45 °C, were reached with Au-CALNN-YIN NPs. These results are in accordance with MTS 
studies and fully correlate with cellular uptake assessment in PC3 cell cultures. Au-CALNN-YIN 
showed the major uptake and the lowest cell viability compared to the other samples. This 
temperature enhancement can be considered as an underestimated value of the actual temperature 
reached inside the cell, principally due to heat dissipation by the cell medium. However, our 
measurement could provide a good estimate of the heat pumped in the cell by the NIR absorption 
of the internalized nanocages, that leads to an intracellular temperature enhancement in the 10-20 
degrees range. 
Morphological changes of cell cytoskeleton upon laser treatment could give an idea of the 
occurred cellular damage. To perform these studies we used scanning electron microscopy 
(SEM). The cells, exposed to 10 min of laser irradiation at above conditions, were processed and 
analyzed by SEM. Temperature rise during irradiation experiment was monitored with 
thermocamera (Figure 8). The maximum temperature reached during irradiation was around 43 
°C for Au-CALNN-YIN NCs, which correlates with the results of maximum cellular uptake. 
While the temperature of the cells, incubated with Au-PVP NCs did not show significant 
temperature rise, very similar to the control cells. Figure 9 indicates visible cellular damage after 
nanoparticle-induced hyperthermia. Untreated PC3 cells showed the presence of numerous 
characteristic microvilli on the cell surface both before and after exposure to NIR laser 
irradiation. In contrast, cells treated with Au-PVP NCs and exposed to NIR radiation showed 
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some morphological changes, such as membrane blebbing and partial reduction in microvilli 
exposure (Figure 9, c). Blebbing was indicative of occurred apoptosis after laser treatment when 
the cell becomes spherical, shaping itself as imposed by the cytoskeleton. As a next step, cell 
was digested and blebs or vesicles formed on its surface. On the other hand, cells treated with 
Au-PVP NCs but not exposed to the laser did not exhibit evidence of damage or apoptosis 
(Figure 9, d). PC3 cells showed complete loss of microvilli with simultaneous shrinkage in size 
compared to non-irradiated cells after treatment with Au-CALNN-INP NPs and exposed to NIR 
irradiation (Figure 9, e, f). Finally, cells treated with Au-CALNN-YIN NPs revealed a 
smoothening of cell surface showing complete loss of surface microvilli and a different 
morphological aspect compared to both Au-PVP NCs and Au-CALNN-INP NPs, suggesting a 
more relevant effect of hyperthermia on the cytoskeleton organization. The presence of 
microvilli on the surface of the malignant cells plays a role in cell migration, attachment and 
invasion, while reduction in microvilli may potentially inhibit cancer cell invasion and, therefore, 
prevent the disease development and diffusion. 
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Figure 9. SEM images showing PC3 cell morphology changes pre- and post-hyperthermia 
treatment with AuNCs: a) untreated PC3 cells, b) PC3 cells irradiated with laser, c) PC3 cells 
incubated with Au-PVP NCs and irradiated with laser, d) PC3 cells incubated with Au-PVP NCs 
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without laser irradiation, e) PC3 cells incubated with Au-CALNN-INP NCs and irradiated with 
laser, f) PC3 cells incubated with Au-CALNN-INP NCs without laser irradiation, g) PC3 cells 
incubated with Au-CALNN-YIN NCs and irradiated with laser, and h) PC3 cells incubated with 
Au-CALNN-YIN NCs without laser irradiation. Scale bars: a,d) 10 µm; b,c,e,f) 3 µm; g,h) 1 µm. 
CONCLUSIONS 
In summary, the design, synthesis and characterization of monodisperse cubic-shaped gold 
nanocages functionalized with three different NPY analogs are reported in this study. The 
peptides were conjugated via a CALNN linker sequence and intercalated by short PEG 
molecules, allowing for an optimized self-assembly on the nanoparticle surface. The resulting 
Au-peptide NCs proved to be unexpectedly long-term stable in biological environment, as no 
cage degradation occurred even in 100% fetal bovine serum and in a broad range of pH (i.e., 
between 2 and 10). AuNCs were used to study the binding and internalization in a PC3 prostate 
cancer cell line, showing highly selective interaction with NPYR and efficient uptake promoted 
by clathrin-mediated endocytosis. TEM images showed a dynamic exchange of AuNCs between 
the cytosolic environment and the external cellular matrix, suggesting an active trafficking 
process of endocytosis/exocytosis/re-endocytosis across the cell membrane. Once loaded with 
AuNCs, cancer cells were irradiated with NIR laser at ca. 800 nm wavelength showing a heating 
enhancement dependent both on the irradiation intensity and nanoparticle uptake. Cells treated 
with Au-peptide NCs were irradiated at 10 W/cm
2
 showing extensive necrosis after 20 min. 
However, further studies will be necessary to elucidate the possible involvement of apoptosis 
pathways in the mechanism of cell death. Interestingly, we observed significant morphological 
changes in the cell cytoskeleton caused by irradiation in PC3 cells bearing AuNCs, consistent 
with cellular damage. In particular, the appearance of membrane blebbing combined with loss of 
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characteristic microvilli could be associated to possible apoptosis and is expected to inhibit both 
proliferation and migration/invasion of cancer cells. The next steps of this research will be to go 
deeper into the elucidation of death mechanisms of cells loaded with NPY-AuNCs promoted by 
irradiation, and to investigate the intracellular pathways and protein expression activated or 
inhibited as a result of photothermal treatment. On the horizon of this study, we envisage 
numerous possible developments aimed at improving the diagnosis and treatment of different 
kinds of tumors well beyond prostate cancer, considering that neuropeptide receptor is found 
overexpressed in several malignancies, including glioblastoma, lymphomas, ovarian and breast 
carcinomas, neuroblastoma, small cell lung cancer, gastric and colorectal carcinomas.
48,49
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Figure 1. Schematic representation of NPYR targeting on prostate cancer cells by peptide-functionalized gold 
nanocages and subsequent hyperthermia by NIR irradiation. Three kinds of AuNCs are considered, deriving 
from the surface functionalization with selected peptides, namely a) CALNN-INP, b) Au-CALNN-Ahx-INP, c) 
Au-CALNN-YIN, respectively. Peptide sequences are sketched in the figure. The available surface of AuNCs 
was saturated by short PEG molecules, HS-(CH2)11-EG6-OH.  
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Figure 2. a) TEM micrographs of as-prepared silver nanocubes - medium size 34.7 ± 2.5 nm (scale bar 50 
nm); b) TEM micrographs of as-prepared Au-PVP NCs (scale bar 500 nm); c) TEM micrographs of as-
prepared Au-PVP NCs – medium size 40.8 ± 1.8 nm (scale bar 50 nm); d) UV-vis spectra of AuNCs before 
and after functionalization with peptides.  
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Figure 3. Time dependence of ERK phosphorylation in PC3 cells in response to specific NPYR targeting by 
nanocages decorated with a) CALNN-INP, b) CALNN-Ahx-INP, and c) CALNN-YIN peptides. Number of 
replicates, n = 3.  
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Figure 4. Confocal microscopy images (162 µm × 162 µm) of PC3 cells incubated with peptide-functionalized 
AuNCs: a) Au-CALNN-INP NPs; b) Au-CALNN-Ahx-INP NPs; c) Au-CALNN-YIN NPs. Cellular membranes are 
stained with AlexaFluor488–conjugated Wheat germ agglutinin (green), while AuNCs are visualized in 
reflection mode (red); d) Cellular uptake quantification by confocal microscopy. Scattering signal per cell 
area is reported after measuring at least 50 cells per sample. The nanoparticle uptake, evaluated by 
summing the scattering signal from all the nanoparticles inside each cell normalized to the cell section area, 
was averaged over at least 50 cells.  
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Figure 5. Gallery of TEM images showing cellular trafficking of Au-CALNN-YIN NCs in PC3 cells. The 
nanocages were incubated with cells for 30 min, 3, 5, 24 and 48 h, processed and visualized by TEM 
microscopy. Scale bars: a,c) 200 nm; b,e,f) 1 µm; d,g) 500 nm; h) 2 µm Small arrows indicate just 
internalized nanocages, while big arrows indicate clathrin formation.  
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Figure 6. Gallery of TEM images showing PC3 cells incubated with Au-CALNN-YIN NCs: the cells were 
treated with nanocages for 24 h and washed with fresh medium (T = 0 h), then re-incubated for further 5 h 
(T = 5 h) or 24 h (T = 24 h). Scale bars: a) 2 µm; b,c,e,f) 500 nm; d,g) 5 µm; h,i) 1 µm.  
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Figure 7. Fluorescence microscopy images of PC3 cells incubated with peptide-conjugated AuNCs: a) AuNCs 
upon NIR irradiation (800 nm, 12.7 W/cm2) for 10 min; b) AuNCs upon NIR irradiation (800 nm, 12.7 
W/cm2) for 20 min. Viable cells are stained in green with calcein AM, dead cells are stained in red with PI. 
All images were collected in tile mode: the overall field of view is 3.1 × 3.1 mm.  
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Figure 8. Upper panel: Time-dependent temperature-rise images of PC3 cells incubated with peptide-
conjugated AuNCs, Au-PVP NCs and control cells. The pictures were obtained by thermocamera during laser 
exposure and show the Petri dish (35 mm diameter) with the central irradiated area. Lower panel: Time-
dependent temperature-rise curves of PC3 cells incubated with peptide-conjugated AuNCs, Au-PVP NCs and 
control cells. Time interval: 5 min. Laser irradiance 12.7 W/cm2, 800 nm.  
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Figure 9. SEM images showing PC3 cell morphology changes pre- and post-hyperthermia treatment with 
AuNCs: a) untreated PC3 cells, b) PC3 cells irradiated with laser, c) PC3 cells incubated with Au-PVP NCs and 
irradiated with laser, d) PC3 cells incubated with Au-PVP NCs without laser irradiation, e) PC3 cells incubated 
with Au-CALNN-INP NCs and irradiated with laser, f) PC3 cells incubated with Au-CALNN-INP NCs without 
laser irradiation, g) PC3 cells incubated with Au-CALNN-YIN NCs and irradiated with laser, and h) PC3 cells 
incubated with Au-CALNN-YIN NCs without laser irradiation. Scale bars: a,d) 10 µm; b,c,e,f) 3 µm; g,h) 1 
µm.  
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